Plain-English translation of NCT06686485 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether two procedures can be safely performed together in one operation for people with atrial fibrillation (a type of irregular heartbeat). The first procedure uses the FARAPULSE Pulsed Field Ablation system to treat the irregular heartbeat, and the second involves implanting a WATCHMAN device to close off a small pouch in the heart called the left atrial appendage. The study will follow participants to see if doing both procedures at the same time is safe and works well.
People with atrial fibrillation often need both a procedure to correct their heart rhythm and a closure device to prevent blood clots. This trial wants to find out if these two treatments can be done together safely and effectively, rather than in separate procedures.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will come to the hospital for a single procedure where doctors will perform both the heart rhythm ablation using the new pulsed field ablation system and implant the closure device during the same operation. After that, you will attend follow-up visits at the study center so the doctors can check how you are doing, monitor your heart rhythm, and make sure both treatments are working safely and effectively. The study will track your health and recovery over time to gather information about how well these two procedures work when done together.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
China